NIH Institute / Center · DA (NIDA)
National Institute on Drug Abuse
246 funded awards, $142.1M total, FY2023-FY2025.
NIH SBIR/STTR funding decisions are made by Institutes and Centers based on portfolio priorities, NOFO scope, and program officer judgment. Historical funding patterns do not guarantee future funding.
Technology areas funded by NIDA
Limitations
- RePORTER includes funded projects only, not unfunded applications.
- Panel sidebar reflects panels that have appeared on funded records, not future assignment.
- FOA-route status reflects verification at the timestamp shown.
Pattern read
NIDA's SBIR portfolio is heavily oriented toward substance-use-disorder treatment tools: behavioral health interventions and health-services technology together make up the bulk of records. Small-molecule therapeutic and medical-device slices follow. 246 records and $142M total. Median award is $399K, on the lower side of the cross-IC range. R44 (126) over R43 (78) is roughly 1.5:1. Concentration is low at 5.3%. NIDA's focus on substance-use clinical relevance has been firm; products framed for general mental health without a substance-use angle have not landed here.